Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan

被引:48
作者
Lin, Yi-Tsung [1 ]
Chiu, Cheng-Hsun [2 ]
Chan, Yu-Jiun [3 ,4 ]
Lin, Mei-Lin [1 ]
Yu, Kwok-Woon [3 ,4 ]
Wang, Fu-Der [1 ,4 ]
Liu, Cheng-Yi [1 ,4 ]
机构
[1] Taipei Vet Gen Hosp, Dept Med, Div Infect Dis, Taipei, Taiwan
[2] Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan
[3] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan
[4] Natl Yang Ming Univ, Taipei 112, Taiwan
关键词
CHRYSEOBACTERIUM-MENINGOSEPTICUM; SUSCEPTIBILITY; DEFINITIONS; MENINGITIS; INFECTIONS;
D O I
10.1080/00365540903089476
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A limited number of reports have documented bacteremia caused by Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) in adults. Most cases have occurred in Taiwan. This study investigated the clinical features and risk factors for mortality from E. meningoseptica bacteremia and the antimicrobial susceptibilities of the isolates. Patients with E. meningoseptica bacteremia were retrospectively analyzed at a medical center/teaching hospital in northern Taiwan over a 3-y period. We analyzed clinical features and outcomes of patients and antimicrobial susceptibilities and pulsed-field gel electrophoresis (PFGE) results of the isolates. 28 patients had nosocomial bacteremia and 4 patients had healthcare associated bacteremia. The isolates exhibited variable susceptibilities to levofloxacin, ciprofloxacin, piperacillin-tazobactam, tigecycline, and trimethoprim-sulfamethoxazole. PFGE demonstrated that most isolates were epidemiologically unrelated. The 28-d mortality rate was 41%. Multivariate analysis indicated that shock and use of inappropriate antibiotics were independent risk factors for mortality. In conclusion, nosocomial bloodstream infection due to E. meningoseptica is an increasing problem in Taiwan. Our study indicates that patients with E. meningoseptica bacteremia face poor prognoses, with shock and use of inappropriate antibiotics as the main risk factors for mortality. Further clinical study is needed to establish the optimal therapy for E. meningoseptica bacteremia.
引用
收藏
页码:628 / 634
页数:7
相关论文
共 18 条
  • [1] Chryseobacterium meningosepticum: An emerging pathogen among immunocompromised adults - Report of 6 cases and literature review
    Bloch, KC
    Nadarajah, R
    Jacobs, R
    [J]. MEDICINE, 1997, 76 (01) : 30 - 41
  • [2] A Chryseobacterium meningosepticum outbreak observed in 3 clusters involving both neonatal and non-neonatal pediatric patients
    Ceyhan, Mehmet
    Yildirim, Inci
    Tekeli, Alper
    Yurdakok, Murat
    Us, Ebru
    Altun, Belgin
    Kutluk, Tezer
    Cengiz, Ali Buelent
    Gurbuz, Venhar
    Barin, Cagri
    Bagdat, Arzu
    Cetinkaya, Duygu
    Gur, Deniz
    Tuncela, Onur
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2008, 36 (06) : 453 - 457
  • [3] Atypical Chryseobacterium meningosepticum and meningitis and sepsis in newborns and the immunocompromised, Taiwan
    Chiu, CH
    Waddingdon, M
    Hsieh, WS
    Greenberg, D
    Schreckenberger, PC
    Carnahan, AM
    [J]. EMERGING INFECTIOUS DISEASES, 2000, 6 (05) : 481 - 486
  • [4] Clinical and Laboratory Standards Institute (CLSI), 2007, M100S17 CLSI
  • [5] Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing
    Fraser, SL
    Jorgensen, JH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (12) : 2738 - 2741
  • [6] CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988
    GARNER, JS
    JARVIS, WR
    EMORI, TG
    HORAN, TC
    HUGHES, JM
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) : 128 - 140
  • [7] Definitions of key terms used in the NNIS system
    Horan, TC
    Emori, TG
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 1997, 25 (02) : 112 - 116
  • [8] Susceptibilities of Chryseobacterium indologenes and Chryseobacterium meningosepticum to cefepime and cefpirome
    Hsueh, PR
    Teng, LJ
    Yang, PC
    Ho, SW
    Luh, KT
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (12) : 3323 - 3324
  • [9] Hung PP, 2008, J MICROBIOL IMMUNOL, V41, P137
  • [10] Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov as Elizabethkingia meningoseptica comb. nov and Elizabethkingia miricola comb. nov.
    Kim, KK
    Kim, MK
    Lim, JH
    Park, HY
    Lee, ST
    [J]. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, 2005, 55 : 1287 - 1293